NuVasive, Inc. (NUVA) - Medical Equipment - Deals and Alliances Profile

Date: July 21, 2016
Pages: 68
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: NF06C04BD52EN
Leaflet:

Download PDF Leaflet

NuVasive, Inc. (NUVA) - Medical Equipment - Deals and Alliances Profile
Summary

NuVasive, Inc. (NuVasive) is a medical device company which offers an extensive selection of minimally-disruptive surgical products and procedurally-integrated solutions for spine. The company’s product portfolio encompasses surgical procedures including transforaminal lumbar interbody fusion (TLIF); posterior lumbar interbody fusion (PLIF); posterior cervical fusion; anterior cervical discectomy and fusion; extreme lateral interbody fusion corpectomy; and anterior lumbar interbody fusion. Its TLIF nad PLIF are based on maximum access surgery (MAS), a minimally-disruptive surgical platform. NuVasive also offers nerve monitoring systems, and cellular allograft as a bone graft substitute in spinal fusion surgery. The company’s products are used for the treatment of indications such as cervical disc degeneration; adult degenerative scoliosis; spondylolisthesis; lumbar degenerative disc disease; lumbar spinal stenosis; and back pain. It markets its products in the Americas, Asia-Pacific and Europe. NuVasive is headquartered in San Diego, California, the US.

NuVasive, Inc. (NUVA) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
NuVasive, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
NuVasive, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
NuVasive, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
NuVasive, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
NuVasive, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
NuVasive, Inc., Medical Equipment, Deal Details
Venture Financing
Ellipse Technologies Secures US$17.6 Million In Series C Financing
Ellipse Technologies Secures US$15 Million In Financing
Ellipse Technologies Secures US$1.8 Million In Financing Round
Partnerships
NuVasive Enters Into Licensing Agreement With AlloSource
Equity Offering
Ellipse Technologies Withdraws IPO for up to USD75 Million
Debt Offering
NuVasive Raises USD650 Million in Private Placement of 2.25% Notes Due 2021
NuVasive Completes Underwritten Public Offering Of Senior Notes Due 2017 For US$402.5 Million
Acquisition
NuVasive Acquires Biotronic NeuroNetwork for USD98 Million
NuVasive to Acquire Mega Surgical
NuVasive to Acquire Ellipse Technologies
Biotronic NeuroNetwork Acquires Neurophysiology Associates, Provider Of Intraoperative Monitoring Services
NuVasive Acquires ANC, Maker Of Spine Implant, For US$4.5 Million
NuVasive Completes Acquisition Of Impulse Monitoring For US$80 Million
Impulse Monitoring Acquires Great Lakes Intraoperative Neuromonitoring
Biotronic NeuroNetwork Acquires US Neuromonitoring
NuVasive, Inc. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Strategy And Business Planning
Dec 10, 2015: NuVasive Announces Location for New State-of-the-Art Manufacturing Facility
Aug 25, 2015: Nuvasive to Significantly Expand Manufacturing
Financial Announcements
Apr 26, 2016: NuVasive Reports First Quarter 2016 Financial Results
Feb 11, 2016: NuVasive Reports Fourth Quarter and Full Year 2015 Financial Results
Jan 12, 2016: NuVasive Announces Select Preliminary Full-Year 2015 Financial Results and Reiterates 2016 Outlook
Oct 27, 2015: NuVasive Reports Third Quarter 2015 Financial Results
Jul 28, 2015: NuVasive Reports Second Quarter 2015 Financial Results
May 04, 2015: NuVasive Reports First Quarter 2015 Financial Results
Feb 24, 2015: NuVasive Reports Fourth Quarter and Full Year 2014 Financial Results
Jan 12, 2015: NuVasive Announces Select Preliminary Unaudited Full-Year 2014 Financial Results and 2015 Outlook
Corporate Communications
Feb 11, 2016: NuVasive Elects Robert F. Friel and Donald J. Rosenberg to Board of Directors
Dec 01, 2015: NuVasive Appoints Jason D. Hanson as Executive Vice President, Strategy, Corporate Development and General Counsel
Aug 18, 2015: NuVasive Appoints Johnson Lai Chief Information Officer
Jul 16, 2015: Nuvasive Taps Veteran Company Leader Jason M. Hannon To Accelerate International Expansion Efforts
Jul 13, 2015: NuVasive CEO Announces New Executive Leadership Team
Jul 06, 2015: NuVasive Elects Daniel J. Wolterman to Its Board of Directors
Jun 15, 2015: NuVasive Elects Vickie L. Capps to Its Board of Directors
May 26, 2015: NuVasive Appoints Gregory T. Lucier Chief Executive Officer
Apr 01, 2015: NuVasive Announces Leadership Transition
Jan 12, 2015: NuVasive Announces Expanded Leadership Roles for Executives Pat Miles and Matt Link
Legal and Regulatory
Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic
Jul 28, 2015: NuVasive Announces Definitive Settlement With United States
Apr 29, 2015: Nuvasive Reaches Agreement In Principle To Settle OIG Matter
Mar 03, 2015: NuVasive Announces Successful Appeal of Medtronic Verdict
Product News
Mar 09, 2016: NuVasive Announces Regulatory Approval of Reline(TM) Posterior Fixation Technology in Japan
Oct 12, 2015: Nuvasive Receives First Ever FDA 510(K) Clearance Of Cervical Corpectomy Cage
Sep 01, 2015: Nuvasive To Launch Integrated Global Alignment Platform For Select International Markets At Eurospine 2015
Product Approvals
Mar 09, 2016: NuVasive Announces Regulatory Approval of Reline(TM) Posterior Fixation Technology in Japan
Oct 12, 2015: Nuvasive Receives First Ever FDA 510(K) Clearance Of Cervical Corpectomy Cage
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

NuVasive, Inc., Medical Equipment, Key Facts, 2015
NuVasive, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
NuVasive, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
NuVasive, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
NuVasive, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
NuVasive, Inc., Deals By Market, 2010 to YTD 2016
NuVasive, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Ellipse Technologies Secures US$17.6 Million In Series C Financing
Ellipse Technologies Secures US$15 Million In Financing
Ellipse Technologies Secures US$1.8 Million In Financing Round
NuVasive Enters Into Licensing Agreement With AlloSource
Ellipse Technologies Withdraws IPO for up to USD75 Million
NuVasive Raises USD650 Million in Private Placement of 2.25% Notes Due 2021
NuVasive Completes Underwritten Public Offering Of Senior Notes Due 2017 For US$402.5 Million
NuVasive Acquires Biotronic NeuroNetwork for USD98 Million
NuVasive to Acquire Mega Surgical
NuVasive to Acquire Ellipse Technologies
Biotronic NeuroNetwork Acquires Neurophysiology Associates, Provider Of Intraoperative Monitoring Services
NuVasive Acquires ANC, Maker Of Spine Implant, For US$4.5 Million
NuVasive Completes Acquisition Of Impulse Monitoring For US$80 Million
Impulse Monitoring Acquires Great Lakes Intraoperative Neuromonitoring
Biotronic NeuroNetwork Acquires US Neuromonitoring
NuVasive, Inc., Key Competitors
NuVasive, Inc., Key Employees
NuVasive, Inc., Other Locations
NuVasive, Inc., Subsidiaries

LIST OF FIGURES

NuVasive, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
NuVasive, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
NuVasive, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
NuVasive, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
NuVasive, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
NuVasive, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
NuVasive, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
NuVasive, Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016
Skip to top


Ask Your Question

NuVasive, Inc. (NUVA) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: